Director Kuang-Tseng Chen resigns; Yu-Min (Francis) Chung appointed as director

ABVC BIOPHARMA, INC.

Kuang-Tseng Chen resigned from the board on July 10, 2022, for personal reasons, effective immediately.
Yu-Min (Francis) Chung appointed to fill the vacancy on the same day.
Chung was a Partner at Maxpro Ventures (2018-2022) and VP at TaiAn Technology (2016-2018).
Chung holds a Ph.D. in Pharmacy from the University of Iowa and an MBA from National Taiwan University.
Directors receive $3,500 monthly compensation; no family relationships or material interests disclosed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Yu-Min (Francis) Chung

Director

ABVC · ABVC BIOPHARMA, INC.

Effective: 2022-07-10
Filed: July 14, 2022, 7:59 PM ET

On July 10, 2022, the board of directors (“Board”) of the Company appointed Mr. Yu-Min (Francis) Chung as a director to fill the vacancy resulting from Mr. Chen’s resignation.

Departed

Kuang-Tseng Chen

Director

ABVC · ABVC BIOPHARMA, INC.

Effective: 2022-07-10
Successor: Yu-Min (Francis) Chung
Filed: July 14, 2022, 7:59 PM ET

On July 10, 2022, Mr. Kuang-Tseng Chen, a director ABVC BioPharma, Inc. (the “Company”) notified the Company of his resignation from the board of directors for personal reasons, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Yu-Min (Francis) Chung was appointed as Director at ABVC BIOPHARMA, INC..

Action: appointed
Role: Director

Exact text from the filing

On July 10, 2022, the board of directors (“Board”) of the Company appointed Mr. Yu-Min (Francis) Chung as a director to fill the vacancy resulting from Mr. Chen’s resignation.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Kuang-Tseng Chen resigned as Director at ABVC BIOPHARMA, INC..

Action: resigned
Role: Director

Exact text from the filing

On July 10, 2022, Mr. Kuang-Tseng Chen, a director ABVC BioPharma, Inc. (the “Company”) notified the Company of his resignation from the board of directors for personal reasons, effective immediately.

View on SEC.gov

ABVC BIOPHARMA, INC. filing history →

Source: SEC EDGAR

accession 0001213900-22-039422

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.